Apoptotic cells in allogeneic hematopoietic stem cell transplantations: "turning trash into gold"

Leukemia and Lymphoma

Volumn 53, Issue 11, 2012, Pages 2130-2135

  Pessach, Ilias ^a   Shimoni, Avichai ^a   Nagler, Arnon ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

Apoptosis; dendritic cells; stem cell transplantation; T cells; tolerance

Indexed keywords

ABC TRANSPORTER; AUTOANTIBODY; CANCER GROWTH FACTOR; HLA ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; TRANSFORMING GROWTH FACTOR BETA;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOIMMUNIZATION; APOPTOSIS; APOPTOTIC CELL; AUTOIMMUNITY; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL COMMUNICATION; CELL FUNCTION; CELL MATURATION; CELL MIGRATION; CELLS; CHIMERA; DISEASE SEVERITY; ENGRAFTMENT; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOMODULATION; INCIDENCE; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; UPREGULATION;

ANIMALS; APOPTOSIS; AUTOIMMUNITY; DENDRITIC CELLS; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MACROPHAGES; TRANSPLANTATION, HOMOLOGOUS;

EID: 84867166717     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.690099     Document Type: Review

References (51)

1. Ferrara JL, Deeg HJ. Graft-versus-host disease. N Engl J Med 1991;324:667-674.
2. Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer 2005;5:275-284. (Pubitemid 40488633)
3. Bleakley M, Riddell SR. Molecules and mechanisms of the graft versus leukaemia ef ect. Nat Rev Cancer 2004;4:371-380.
4. Erlich HA, Opelz G, Hansen J. HLA DNA typing and transplantation. Immunity 2001;14:347-356. (Pubitemid 32441587)
5. Welniak LA, Blazar BR, Murphy WJ. Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu Rev Immunol 2007;25:139-170. (Pubitemid 46697905)
6. Appelbaum FR. Haematopoietic cell transplantation as immunotherapy. Nature 2001;411:385-389. (Pubitemid 32467049)
7. Slavin S, Nagler A, Naparstek E, et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998;91:756-763. (Pubitemid 28078275)
8. Sykes M, Pref er F, McAfee S, et al. Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation. Lancet 1999;353:1755-1759. (Pubitemid 29240375)
9. Khouri IF, Saliba RM, Giralt SA, et al. Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft versus host disease, and treatment-related mortality. Blood 2001;98:3595-3599.
10. McSweeney PA, Niederwieser D, Shizuru JA, et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft versus tumor effects. Blood 2001;97:3390-3400.
11. Loiseau P, Busson M, Balere ML, et al. HLA association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A,-B,-C,-DRB1, or-DQB1 is strongly associated with overall survival. Biol Blood Marrow Transplant 2007;13:965-974. (Pubitemid 47055388)
12. Hahn T, McCarthy PL Jr, Zhang MJ, et al. Risk factors for acute graft versus host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia. J Clin Oncol 2008;26:5728-5734.
13. Kernan NA, Bartsch G, Ash RC, et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993;328:593-602. (Pubitemid 23065358)
14. Flomenberg N, Baxter-Lowe LA, Confer D, et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse ef ect on transplantation outcome. Blood 2004;104:1923-1930. (Pubitemid 39297840)
15. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med 2006;354:1813-1826.
16. Koreth J, Matsuoka K, Kim HT, et al. Interleukin-2 and regulatory T cells in graft-versus-host disease. N Engl J Med 2011;365:2055-2066.
17. Yoo EK, Rook AH, Elenitsas R, et al. Apoptosis induction of ultraviolet light A and photochemotherapy in cutaneous T-cell lymphoma: relevance to mechanism of therapeutic action. J Invest Dermatol 1996;107:235-242. (Pubitemid 26254840)
18. Lucas M, Stuart LM, Savill J, et al. Apoptotic cells and innate immune stimuli combine to regulate macrophage cytokine secretion. J Immunol 2003;171:2610-2615. (Pubitemid 37025573)
19. Huynh ML, Fadok VA, Henson PM. Phosphatidylserine dependent ingestion of apoptotic cells promotes TGF-beta 1 secretion and the resolution of inf ammation. J Clin Invest 2002;109:41-50. (Pubitemid 34052540)
20. Barker RN, Erwig L, Pearce W P, et al. Dif erential effects of necrotic or apoptotic cell uptake on antigen presentation by macrophages. Pathobiology 1999;67:302-305. (Pubitemid 30135929)
21. Steinman RM, Turley S, Mellman I, et al. The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 2000;191:411-416.
22. Maeda A, Schwarz A, Kernebeck K, et al. Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen specif c regulatory T cells. J Immunol 2005;174:5968-5976. (Pubitemid 40663783)
23. Gatza E, Rogers CE, Clouthier SG, et al. Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells. Blood 2008;112:1515-1521.
24. Reed JC. Dysregulation of apoptosis in cancer. J Clin Oncol 1999; 17:2941-2953. (Pubitemid 29415256)
25. Fadok VA, Voelker DR, Campbell PA, et al. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specif c recognition and removal by macrophages. J Immunol 1992;148:2207-2216.
26. Henson PM, Bratton DL, Fadok VA. Apoptotic cell removal. Curr Biol 2001;11:R795-R805. (Pubitemid 32931008)
27. Mevorach D. Opsonization of apoptotic cells. Implications for uptake and autoimmunity. Ann NY Acad Sci 2000;926:226-235. (Pubitemid 32050159)
28. Fadok VA, Bratton DL, Konowal A, et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinf ammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 1998;101:890-898. (Pubitemid 28096086)
29. Verbovetski I, Bychkov H, Trahtemberg U, et al. Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7. J Exp Med 2002;196:1553-1561. (Pubitemid 36026467)
30. Skoberne M, Beignon AS, Larsson M, et al. Apoptotic cells at the crossroads of tolerance and immunity. Curr Top Microbiol Immunol 2005;289:259-292. (Pubitemid 40283467)
31. Skoberne M, Somersan S, Almodovar W, et al. The apoptotic cell receptor CR3, but not {alpha}v{beta}5, is a regulator of human dendritic cell immunostimulatory function. Blood 2006;108:947-955. (Pubitemid 44154630)
32. Ronchetti A, Rovere P, Iezzi G, et al. Immunogenicity of apoptotic cells in vivo: role of antigen load, antigen-presenting cells, and cytokines. J Immunol 1999;163:130-136. (Pubitemid 29295833)
33. Chen W, Frank ME, Jin W, et al. TGF-beta released by apoptotic T cells contributes to an immunosuppressive milieu. Immunity 2001; 14:715-725. (Pubitemid 32592419)
34. Feng H, Zeng Y, Graner MW, et al. Exogenous stress proteins enhance the immunogenicity of apoptotic tumor cells and stimulate antitumor immunity. Blood 2003;101:245-252. (Pubitemid 36025914)
35. Steinman RM, Turley S, Mellman I, et al. The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 2000;191:411-416.
36. Bittencourt MC, Perruche S, Contassot E, et al. Intravenous injection of apoptotic leukocytes enhances bone marrow engraftment across major histocompatibility barriers. Blood 2001;98:224-230.
37. Mevorach D, Zhou JL, Song X, et al. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med 1998;188:387-392. (Pubitemid 28357766)
38. Perruche S, Kleinclauss F, Angonin R, et al. A single intravenous infusion of apoptotic cells, an alternative cell-based therapy approach facilitating hematopoietic cell engraftment, did not induce autoimmunity. Hematother Stem Cell Res 2003;12:451-459. (Pubitemid 36993433)
39. Gallucci S, Matzinger P. Danger signals: SOS to the immune system. Curr Opin Immunol 2001;13:114-119. (Pubitemid 32096970)
40. Sawalha AH, Harley JB. Antinuclear autoantibodies in systemic lupus erythematosus. Curr Opin Rheumatol 2004;16:534-540. (Pubitemid 39128320)
41. Perniok A, Wedekind F, Herrmann M, et al. High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus. Lupus 1998;7:113-118. (Pubitemid 28107976)
42. Munoz LE, Lauber K, Schiller M, et al. The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol 2010;6:280-289.
43. Tabas I. Macrophage death and defective inf ammation resolution in atherosclerosis. Nat Rev Immunol 2010;10:36-46.
44. Condeelis J, Pollard JW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006;124:263-266. (Pubitemid 43121975)
45. Murdoch C, Giannoudis A, Lewis CE. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 2004;104:2224-2234. (Pubitemid 39331817)
46. Kerr JF, Winterford CM, Harmon BV. Apoptosis. Its signif cance in cancer and cancer therapy. Cancer 1994;73:2013-2026. (Pubitemid 24107952)
47. Perruche S, Kleinclauss F, Bittencourt Mde C, et al. Intravenous infusion of apoptotic cells simultaneously with allogeneic hematopoietic grafts alters anti-donor humoral immune responses. Am J Transplant 2004;4:1361-1365. (Pubitemid 39013586)
48. Kleinclauss F, Perruche S, Masson E, et al. Intravenous apoptotic spleen cell infusion induces a TGF-beta-dependent regulatory T-cell expansion. Cell Death Difer 2006;13:41-52.
49. Qiu CH, Miyake Y, Kaise H, et al. Novel subset of CD8alpha + dendritic cells localized in the marginal zone is responsible for tolerance to cell-associated antigens. J Immunol 2009;182:4127-4136.
50. Swiecki M, Colonna M. Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance. Immunol Rev 2010;234:142-162.
51. Bonnefoy F, Perruche S, Couturier M, et al. Plasmacytoid dendritic cells play a major role in apoptotic leukocyte-induced immune modulation. J Immunol 2011;186;5696-5705.